Clinical Trials Browser

Phase 1/2 × Recurrence × veliparib × Clear all

NCT01472783 2016-11-16

Veli-BRCA

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence